Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 417,200 | 260,100 | 264,600 | 240,100 | 163,300 |
| Receivables | 949,000 | 969,000 | 1,055,500 | 843,500 | 918,500 |
| Inventories | 2,016,600 | 2,024,200 | 1,987,300 | 1,974,300 | 1,975,400 |
| Other current assets | 488,900 | 445,600 | 449,000 | 435,900 | 410,900 |
| TOTAL | $3,871,700 | $3,698,900 | $3,756,400 | $3,493,800 | $3,468,100 |
| Non-Current Assets | |||||
| PPE Net | 1,467,900 | 1,463,500 | 1,475,600 | 1,482,200 | 1,553,900 |
| Investments And Advances | 49,800 | 0 | 0 | 0 | 55,100 |
| Intangibles | 6,764,900 | 6,867,300 | 6,890,400 | 6,693,000 | 6,783,200 |
| Other Non-Current Assets | 216,299 | 302,000 | 273,500 | 282,300 | 231,600 |
| TOTAL | $8,498,899 | $8,632,800 | $8,639,500 | $8,457,500 | $8,623,800 |
| Total Assets | $12,370,600 | $12,331,700 | $12,395,900 | $11,951,300 | $12,091,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 11,700 | 9,900 | 9,600 | 5,000 |
| Accounts payable and accrued liabilities | 468,500 | 417,900 | 396,400 | 349,900 | 387,700 |
| Other current liabilities | 943,800 | 922,200 | 895,700 | 692,900 | 765,800 |
| TOTAL | $1,463,600 | $1,388,200 | $1,356,500 | $1,081,700 | $1,190,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,413,300 | 4,428,400 | 4,724,900 | 4,923,200 | 4,688,600 |
| aiOther Non-Current Liabilities | 744,199 | 702,100 | 688,900 | 705,201 | 811,900 |
| TOTAL | $5,801,299 | $5,858,400 | $6,135,700 | $6,334,101 | $6,202,200 |
| Total Liabilities | $7,264,900 | $7,246,600 | $7,492,200 | $7,415,800 | $7,392,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 151,978 | 150,342 | 150,247 | 150,198 | 150,151 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 7,135,400 | 7,153,200 | 7,057,600 | 6,987,000 | 7,046,200 |
| Other shareholders' equity | -193,300 | -229,100 | -297,300 | -583,700 | -459,000 |
| TOTAL | $5,105,700 | $5,085,100 | $4,903,700 | $4,535,500 | $4,699,600 |
| Total Liabilities And Equity | $12,370,600 | $12,331,700 | $12,395,900 | $11,951,300 | $12,091,900 |